Search for: "Price v. Phillips" Results 261 - 280 of 337
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Aug 2022, 12:11 pm by INFORRM
   Dissenting, Phillips LJ described the approach of the majority as “unprincipled,” remarking that it would be “unfortunate” if the Appellant “having been denied a fair trial in Bangladesh in 2013 … was now prevented from having access to the courts of this jurisdiction. [read post]
27 Jul 2007, 7:18 am
  Gideon at a public defender reports on State v. [read post]
22 Jul 2022, 6:33 am by Gus Hurwitz
But surely she is correct: in a post-West Virginia v. [read post]
18 Dec 2011, 4:11 pm by INFORRM
First, there was the judgment of Mr Justice Tugendhat in the case of Andre v Price [2010] EWHC 2572 (QB) – given on 11 October 2010. [read post]
28 Apr 2008, 11:00 am
: (Spicy IP), US: Who’s to blame for rising drug prices? [read post]
20 Nov 2011, 4:20 pm by INFORRM
We have had previous posts on the cases of Robins v Kordowski [2011] EWHC 981 (QB)) (seehere), Awdry, Bailey and Douglas v Kordowksi, Farrall v Kordowksi [2010] EWHC 2436 (QB) (see here), Phillips v Kordowski and Mazzola v Kordowski. [read post]
26 Sep 2008, 11:45 pm
(Techdirt)   India Warner loses Hari Puttar case before Delhi High Court for delay in taking action and suppression of material facts (SPICY IP) (IPKat) (Techdirt) (SPICY IP) (Innovationpartners) Delay in evidence suffocates trade mark opposition: Pidilite Industries Limited v Registrar of Trademarks (International Law Office) Delhi High Court rules in Wipro's favour in its trade mark infringement action against local Delhi company (RelatIP) Delhi High Court: Mattel… [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle), (In … [read post]
3 Sep 2013, 1:38 am by Kevin LaCroix
: On August 19, 2013, in connection with its entry into a settlement with New York-based hedge fund adviser Phillip Falcone and his advisory firm Harbinger Capital Partners, the SEC for the first time implemented its new policy requiring defendants seeking to settle civil enforcement actions to admit wrongdoing, in contrast to the long-standing practice of allowing defendants to resolve the enforcement actions with a “neither-admit-nor-deny” settlement. [read post]
11 Dec 2018, 5:31 am by Barry Sookman
Broad exceptions also result in value gaps[14] where creators cannot negotiate market prices and are not adequately compensated, or compensated at all.[15] You have heard that exceptions are needed to promote “innovation”. [read post]
24 Dec 2023, 9:05 pm by The Regulatory Review
How Patents Contribute to High Drug Prices October 16, 2023 | Laura Dolbow, University of Pennsylvania Carey Law School Patents covering drugs selected for Medicare price negotiation show how patents influence drug prices. [read post]